头痛
降钙素基因相关肽
医学
降钙素
原发性头痛
疾病
重症监护医学
生物信息学
受体
生物
内科学
精神科
神经肽
作者
Roberto De Icco,Cristina Tassorelli
标识
DOI:10.1016/s1474-4422(21)00425-7
摘要
In the past decade, the strenuous efforts of the scientific community have substantially advanced our understanding of primary headaches. This research has promoted the development of novel disease-specific treatments, such as monoclonal antibodies and small molecules targeting the calcitonin gene-related peptide (CGRP) pathway, and agonists of the 5-HT1F receptor. However, despite these major advances, primary headaches still constitute a challenge for clinicians and a major burden for patients and society.
科研通智能强力驱动
Strongly Powered by AbleSci AI